5 ms·
Disappointed no one brought up the regulatory hurdles involved when discussing the resistance of the industry to disruption. When the cost to bring a new drug t
by Tossrock 11y ago
Disappointed no one brought up the regulatory hurdles involved when discussing the resistance of the industry to disruption. When the cost to bring a new drug to market is over 2 billion dollars [1], it's hard to see start-ups competing in that environment.
1: http://www.scientificamerican.com/article/cost-to-develop-new-pharmaceutical-drug-now-exceeds-2-5b/ http://www.scientificamerican.com/article/cost-to-develop-ne...
- adenadel 11y agoConsidering that a16z said that they are focusing on software around biotech and not on traditional biotech I think it makes sense that they aren't talking about regulatory hurdles or the cost to bring a drug to market. Eroom's law is a serious problem, and it is hard to imagine a disruptive startup that could compete in that environment.